Convergent evidence for the antiviral effects of several FDA-approved phenothiazine antipsychotics against SARS-CoV-2 and other coronaviruses

Machado-Vieira, Rodrigo; Quevedo, João; Shahani, Lokesh; Soares, Jair C.

Machado-Vieira, Rodrigo; Quevedo, João; Shahani, Lokesh; Soares, Jair C..

Machado-Vieira, Rodrigo; The University of Texas Health Science Center at Houston (UTHealth). Faillace Department of Psychiatry and Behavioral Sciences, McGovern Medical School. Experimental Therapeutics and Molecular Pathophysiology Program. Houston. US
Quevedo, João; UTHealth. Faillace Department of Psychiatry and Behavioral Sciences, McGovern Medical School. Center of Excellence in Mood Disorders. Houston. US
Shahani, Lokesh; UTHealth. Faillace Department of Psychiatry and Behavioral Sciences, McGovern Medical School. Center of Excellence in Mood Disorders. Houston. US
Soares, Jair C.; The University of Texas Health Science Center at Houston (UTHealth). Faillace Department of Psychiatry and Behavioral Sciences, McGovern Medical School. Experimental Therapeutics and Molecular Pathophysiology Program. Houston. US

Braz. J. Psychiatry (São Paulo, 1999, Impr.) ; 43(5): 462-464, Sept.-Oct. 2021. tab

Artículo en Inglés | LILACS | ID: biblio-1345475

Asunto(s)

Humanos; Antipsicóticos; COVID-19; Antivirales/uso terapéutico; Fenotiazinas; SARS-CoV-2

Texto completo

Imprimir

XML

Buscar en Google

Texto completo: Disponible Índice: LILACS (Américas) Asunto principal: Antipsicóticos / COVID-19 Límite: Humanos Idioma: Inglés Revista: Braz. J. Psychiatry (São Paulo, 1999, Impr.) Asunto de la revista: Psiquiatria Año: 2021 Tipo del documento: Artículo País de afiliación: Estados Unidos Institución/País de afiliación: The University of Texas Health Science Center at Houston (UTHealth)/US / UTHealth/US

Similares

MEDLINE

LILACS

LIS

Texto completo

Imprimir

XML

Buscar en Google